Serene: Innovation in Non-Invasive Prenatal Screening by Germano de Sousa Laboratories
Prenatal Diagnostics is one of the Germano de Sousa Group’s areas of excellence, where the highest quality standards come together to offer expectant mothers and their families a trustworthy and safe experience during prenatal screening.
With decades of dedication to healthcare, our laboratories—recognized by the Fetal Medicine Foundation (FMF) as a leader in first-trimester combined screening—continue to lead the way with life-changing advancements. The latest development is Serene, a non-invasive prenatal screening test that redefines standards of reliability and trust.
Serene: Cutting-Edge Technology in the Service of Motherhood
Serene is a revolutionary advance in prenatal screening, enabling the precise analysis of fetal DNA through a simple sample of maternal blood. This non-invasive method eliminates the risks associated with traditional procedures, such as amniocentesis, while providing robust and detailed results.
What Makes Serene Unique?
- Sensitivity exceeding 99% in detecting trisomies such as 21 (Down syndrome), 18, and 13, in addition to identifying fetal sex.
- Assessment of the risk of additional chromosomal abnormalities, with analysis of all chromosomes.
- Next-generation mass sequencing (NGS), ensuring maximum accuracy.
- A dual algorithm for risk prediction and fetal fraction calculation, optimizing the accuracy of the results.
- Enrichment of the fetal fraction, ensuring a greater amount of genetic material from the fetus and guaranteeing a high-quality report.
| Chromosomal Abnormality | Detection | False Positives |
|---|---|---|
| T21 (Down Syndrome) | >99% | 0.1% |
| T18 (Edwards Syndrome) | >99% | 0.1% |
| T13 (Patau syndrome) | >99% | 0.1% |
| Y Chromosome Detection | 100% | - |
Published data: Mark D. Pertile et al., Clinical Chemistry, Volume 67, Issue 9, September 2021
Testimonials
According to Professor Maria José Rego de Sousa, head of the Department of Prenatal Diagnostics: “Serene offers the best detection rates for all trisomies when compared to other non-invasive screening tests.”
One of Serene’s key strengths is its ability to provide accurate results even in samples with low fetal fractions. As Dr. Ana Guia Pereira, Director of the Genetics Department at the Germano de Sousa Group, points out:
“Thanks to the use of CE-IVDR-marked software, Serene ensures maximum accuracy even under challenging conditions.”
Why Choose Serene?
Choosing Serene goes beyond scientific accuracy. It’s a choice for peace of mind and confidence during the most sensitive period of pregnancy. This test offers:
- Greater safety for the mother and baby, avoiding invasive procedures.
- A comprehensive approach that enables more informative prenatal care.
- Quick results, helping healthcare professionals and families make safer, more informed decisions.
Germano de Sousa Laboratories: Excellence and Innovation
At Germano de Sousa Laboratories, we understand that every pregnancy is unique and deserves special care. That’s why we continue to invest in innovative solutions, such as Serene, to ensure that expectant mothers have access to the best that science has to offer.
We combine experience, cutting-edge technology, and a patient-centered approach to transform moments of uncertainty into journeys of confidence and serenity.
Germano de Sousa Group, THE LABORATORY OF PORTUGAL.
Learn more at: https://www.germanodesousa.com/areas-clinicas/serene-rastreio-pre-natal-nao-invasivo/
The SERENE test is now covered by Médis
If you have any questions, please contact us.
We'll be happy to help.
CLINICAL PATHOLOGY LABORATORY
